Efficacy of A Novel RinSe Device to Reduce Oral Bacteria in Intubated IntEnsive CaRe Patients: a Pilot Study
Launched by THE CLEVELAND CLINIC · Dec 20, 2023
Trial Information
Current as of July 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new device called the Swiftsure SwishKit, which aims to reduce harmful bacteria in the mouths of patients who are on a ventilator (a machine that helps them breathe) in the intensive care unit. The study will compare the usual oral care these patients receive with the additional use of this new device to see which one is more effective in keeping their mouths healthier and reducing infections.
To participate, individuals need to be at least 18 years old and must be intubated (have a tube placed in their throat to help them breathe) for at least two days. However, people with certain conditions, like facial injuries or infections, or those who have been intubated for over 24 hours in the past week, will not be eligible. Participants will need to give their consent or have a legal representative provide consent on their behalf. This trial is an important step in finding better ways to care for patients who are critically ill and on mechanical ventilation.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults, 18 years or older
- • Individual or legally authorized representative consent
- • Intubated with an oral endotracheal tube and expected to remain intubated for at least 2 days.
- Exclusion Criteria:
- • Maxillofacial trauma (current maxillofacial trauma precluding standard oral care techniques)
- • Conditions precluding lateral Trendelenburg positioning (e.g., increased intracranial pressure, spinal instability, hemodynamic instability)
- • Oropharyngeal injury or infection
- • Orofacial edema precluding access for oral care
- • Known or anticipated difficult intubation
- • Endotracheal cuff air leak that clinicians believe precludes mouth lavage
- • Already intubated for more than 24 continuous hours within a week before enrollment.
About The Cleveland Clinic
The Cleveland Clinic is a renowned nonprofit academic medical center based in Cleveland, Ohio, recognized for its commitment to advancing healthcare through innovative research and clinical excellence. As a leading sponsor of clinical trials, the Cleveland Clinic leverages its multidisciplinary expertise and state-of-the-art facilities to conduct groundbreaking studies aimed at improving patient outcomes across a wide range of medical conditions. With a strong emphasis on patient-centered care, the institution fosters collaboration among researchers, clinicians, and patients to explore new treatments and therapies, contributing significantly to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cleveland, Ohio, United States
Patients applied
Trial Officials
Marcelo Gama de Abreu, MD
Principal Investigator
The Cleveland Clinic
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported